These findings suggest that LBP alleviates nasal mucosal inflammation in allergic rhinitis by inhibiting the expression of TLR4/NF-κB pathway-related proteins, restoring Th1/Th2 cytokine balance, and reducing IgE production (49). The gene discussed is TLR4; the disease is allergic rhinitis.